1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generic Drug

The Business of Generics: Market Trends & Strategies Explained

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
24 votes

Global Generic Drug Industry

The generic drug industry (as a part of the pharmaceutical business) covers the marketing and sale of medication containing the same active ingredients and dosages as brand-name drugs manufactured by the pharmaceutical industry. Drugs can be prescribed under their chemical name without specifying a particular pharmaceutical brand or company. A key benefit of generic drugs is that they usually cost a fraction of the price of brand-name drugs, as much as 80% to 85% less according to the US Food and Drug Administration. For example, Glucotrol, a drug used in the treatment of diabetes, represents a monthly cost to patients of between $42 and $84 for 10 mg tablets; however, the drug’s generic version, Glipizide, costs up to 10 times less at between $4 and $8 per month.

Generic drugs are under the same governance as brand-name drugs and must adhere to the same standards. When brand-name drugs come off patent, the market is opened up to generic versions. Patent protection generally protects a drug’s intellectual property rights for about 20 years, but as the patent is effective from the clinical trial stage, the actual time the drug is on the market can be far less, often between 10 and 14 years. After a patent expires, pharmaceutical companies come under fierce pricing pressure due to competition from their less-expensive generic counterparts.

Generics help reduce government spending on healthcare, accounting in part for a near 5% decrease in US drug spending, reports the FDA. The FDA acts as a governing body for generic drugs to enforce maximum standards of variation with brand-name drugs. However, in an 11-year study, variation in absorption of branded and generic drugs was found to be as little as 3.5%. Such negligible variation could equally exist in a comparison of two branded drugs.

Best-Selling Generic Drugs

Generic drugs took all of the top-10 spots for the most-prescribed drugs in the US last year, as ranked by the IMS Institute for Healthcare Informatics. Only three brand-name drugs ranked in the top 25, highlighting the strong foothold secured by generics.

Possibly further boosting future sales is the looming patent expiration of several of the pharmaceutical world’s star prescription brand-name drugs, for which generics are poised to claim a sizeable market share. Top generic drugs to enter the market this year are expected to be Methylphenidate (an attention deficit hyperactivity disorder drug taking over from Concerta) and Levofloxacin (a copy of antibiotic Levaquin).

Other generics set to take over from brand-name drugs include:

  • Fenofibrate based on the cholesterol drug Tricor
  • Montelukast based on asthma and allergy treatment Singulair
  • Pioglitazone based on the diabetic drug Actos
  • Valsartan based on the high blood pressure medication Diovan

Industry Leaders

BCC Research shows Teva Pharmaceutical Industries to hold just under 20% of the global generic drugs market, followed by Sandoz, with 10% of the market. In joint third place are Watson and Mylan, with 6% each. Together, Teva, Sandoz, Watson, and Mylan hold a combined 40% share of the global market.

Generic Drug Industry Trends

The generic drug market is gaining increasing ground over brand-name pharmaceuticals, with the FDA reporting that generics account for more than 70% of prescription drugs in the US. 

 

Leading Associations

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+1 646 893 5945

1-10 of about 400 reports

Global Generic Drug Industry

  • January 2017
    7 pages
  • Generic Drug  

  • World  

    United States  

View report >

Generic Drug Industry in the US

  • September 2017
    30 pages
  • Generic Drug  

    Therapy  

  • United States  

View report >

Generic Drug Industry in the US and Europe

  • September 2017
    49 pages
  • Generic Drug  

    Pharmaceutical  

  • United States  

    Europe  

View report >

Generic Drug Markets in Japan - Forecast

  • January 2016
    13 pages
  • Generic Drug  

    Pharmacy  

  • Japan  

View report >

Generic Drug Industry in the UK

  • January 2015
    57 pages
  • Generic Drug  

  • United Kingdom  

    United States  

View report >

Generic Drug Markets in Canada - Forecast

  • August 2017
    6 pages
  • Generic Drug  

  • Canada  

    North America  

View report >

Generic Drug Industry in China - Forecast

  • January 2016
    12 pages
  • Pharmaceutical  

    Generic Drug  

  • China  

    Asia  

View report >

Generic Drug Industry in Australia - Forecast

  • January 2017
    9 pages
  • Generic Drug  

    Biosimilar  

  • Australia  

    OECD  

    Oceania  

View report >

Generic Drug Industry in Australia - Forecast

  • January 2017
    9 pages
  • Generic Drug  

    Biosimilar  

  • Australia  

    OECD  

    Oceania  

View report >

Generic Drug Industry in Australia

  • September 2016
    8 pages
  • Generic Drug  

  • Australia  

View report >

Search in Generic Drug Industry (About 400 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Drug Discovery and Development, OTC, Pharmacy, Prescription Drug, Therapy

About 200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 199 - $ 4950)

Global Generic Pharmaceuticals Market

  • $ 4950
  • Industry report
  • May 2016
  • by Frost & Sullivan

Market Participants Aim at High Valued-added Segments, with a Big Emphasis on Branded Generics and Biosimilars The key objectives of this research service are to gain an in-depth knowledge of the majo ...

Generic Drugs Markets In China

May 2017 $ 4000

Pharma Leader Series: Top Generic Drug Producers Market ...

July 2017 $ 3247

Generic Drugs Market Forecast 2017-2027

January 2017 $ 3247

The Future Of Generic Drugs And Strategies For Commerci ...

September 2016 $ 2995

Global Generic Drugs Market 2016-2020

May 2016 $ 2500

Generic Drugs Market In India 2017

April 2017 $ 1995

Generic Drugs Companies In China

May 2017 $ 1800

Generic Drugs Industry Forecasts - China Focus

May 2017 $ 1800

Gcc Generic Drug Market: Industry Trends, Share, Size, ...

August 2017 $ 1799

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.